LONG-TERM HEPATOPROTECTIVE EFFECTS OF GLP-1RA IN OBESE PATIENTS WITH TYPE 2 DIABETES: A RETROSPECTIVE COHORT STUDY

被引：0
|
作者：
Khataniar, Himsikhar [1 ]
Dharia, Ashni [1 ]
Desai, Aakash [2 ]
Butt, Muhammad Ali [1 ]
Babich, Michael [1 ]
Mohy-ud-din, Nabeeha [1 ]
机构：
[1] Allegheny Gen Hosp, Pittsburgh, PA USA
[2] Mayo Clin Jacksonville, Jacksonville, FL USA
来源：
HEPATOLOGY | 2024年 / 80卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1625
引用
收藏
页数：2
相关论文
共 50 条
  • [31] The Effect of Early Response to GLP-1 RA Therapy on Long-Term Adherence and Persistence Among Type 2 Diabetes Patients in the United States
    Durden, Emily
    Liang, Michael
    Fowler, Robert
    Panton, Ulrik Haagen
    Mocevic, Emina
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (06): : 669 - +
  • [32] Long-term evolution of renal function in patients with type 2 diabetes mellitus: a registry-based retrospective cohort study
    Goderis, Geert
    Van Pottelbergh, Gijs
    Truyers, Carla
    Van Casteren, Viviane
    De Clercq, Etienne
    Van den Broeke, Carine
    Buntinx, Frank
    BMJ OPEN, 2013, 3 (12):
  • [33] Influence of Timing of Insulin Initiation on Long-term Glycemic Control in Japanese Patients with Type 2 Diabetes: A Retrospective Cohort Study
    Miyazaki, Takashi
    Shirakawa, Jun
    Nagakura, Jo
    Shibuya, Makoto
    Kyohara, Mayu
    Okuyama, Tomoko
    Togashi, Yu
    Nakamura, Akinobu
    Kondo, Yoshinobu
    Satoh, Shinobu
    Nakajima, Shigeru
    Taguri, Masataka
    Terauchi, Yasuo
    INTERNAL MEDICINE, 2019, 58 (23) : 3361 - 3367
  • [34] Deintensification of basal-bolus insulin after initiation of GLP-1RA in patients with type 2 diabetes under routine care
    Bonora, Benedetta Maria
    Rigato, Mauro
    Frison, Vera
    D'Ambrosio, Michele
    Tadiotto, Federica
    Lapolla, Annunziata
    Simioni, Natalino
    Paccagnella, Agostino
    Avogaro, Angelo
    Fadini, Gian Paolo
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2021, 173
  • [35] Real-World Glycemic Control from GLP-1RA Therapy with and Without Concurrent Insulin in Patients with Type 2 Diabetes
    Singhal, Mukul
    Unni, Sudhir
    Schauerhamer, Marisa
    Nguyen, Hiep
    Hurd, Jeff
    McAdam-Marx, Carrie
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2017, 23 (03): : 267 - 275
  • [36] Safety and Efficacy of Long-Term Use of GLP-1RA in Post-Transplant Diabetes Mellitus (PTDM): Analysis of Dulaglutide vs. Liraglutide
    Mallik, Ritwika
    Mukuba, Dorcas
    Casabar-Licayan, Mahalia
    Fan, Stanley
    Mccafferty, Kieran
    Ali, Omer
    Yaqoob, Muhammad Magdi
    Chowdhury, Tahseen A.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 558 - 558
  • [37] Adding a Glucagon like peptide-1 analogue (GLP-1RA) has a favourable effect on mortality and cardiovascular events among insulin-treated patients with Type 2 diabetes: a large retrospective UK cohort study
    Anyanwagu, U. C.
    Mamza, J. B.
    Donnelly, R.
    Idris, I.
    DIABETIC MEDICINE, 2017, 34 : 17 - 17
  • [38] Eating Behavior Is Associated with Long-term Weight Loss Following GLP-1 RA Treatment in Type 2 Diabetes on Insulin
    De Boer, Stefanie A.
    Mulder, Douwe J.
    Lefrandt, Joop D.
    Hoogenberg, Klaas
    DIABETES, 2014, 63 : A248 - A248
  • [39] Real-World Adherence and Discontinuation of GLP-1 Receptor Agonist (GLP-1RA) Therapy in Type 2 Diabetes (T2D) Patients in the US
    Weiss, Tracey
    Iglay, Kristy
    Carr, Richard D.
    Mishra, Ajay Pratap
    Yang, Lingfeng
    Rajpathak, Swapnil
    DIABETES, 2019, 68
  • [40] GLP-1 RA and Risk of Malignancy in Patients with Type 2 Diabetes
    Ishola, Faidat A.
    Pike, C. William
    Kim, Sun H.
    DIABETES, 2024, 73
12345